Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Arch Therapeutics Inc (ARTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 70,093
  • Shares Outstanding, K 154,050
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,790 K
  • 36-Month Beta 0.87
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 35.01
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/19/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3600 +28.89%
on 06/07/18
0.5200 -10.77%
on 05/25/18
+0.0041 (+0.89%)
since 05/22/18
3-Month
0.2600 +78.46%
on 04/30/18
0.5200 -10.77%
on 05/25/18
+0.1340 (+40.61%)
since 03/22/18
52-Week
0.2500 +85.60%
on 12/18/17
0.8900 -47.87%
on 08/28/17
-0.0310 (-6.26%)
since 06/22/17

Most Recent Stories

More News
Arch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization Study

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel and solid hemostatic and wound care devices, announced today that it has completed enrollment for its human skin...

ARTH : 0.4640 (+1.98%)
Arch Therapeutics to Provide Corporate Update at the 8th LD Micro Invitational on Monday, June 4, 2018

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the 8 LD Micro Invitational....

ARTH : 0.4640 (+1.98%)
Arch Therapeutics Provides Update on Study Initiation and 510(k)

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel and solid hemostatic and wound care devices, today announced that it will initiate the previously disclosed study...

ARTH : 0.4640 (+1.98%)
Arch Therapeutics Provides Update on 510(k)

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel and solid hemostatic and wound care devices, today announced that it has utilized the Food and Drug Administration's...

ARTH : 0.4640 (+1.98%)
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market presenting companies...

KSHB : 5.1100 (+0.29%)
EVLLF : 0.7640 (-6.49%)
OPRX : 10.40 (+0.29%)
DMIFF : 0.2900 (-3.33%)
CORVF : 1.7697 (+1.71%)
IMPZY : 1.6000 (unch)
CHPE : 18.1250 (+0.14%)
CBWTF : 0.9600 (-4.81%)
ATMS : 1.0101 (unch)
RSSS : 1.7000 (-0.58%)
FSSN : 0.1700 (+3.03%)
MSRT : 0.2500 (-1.96%)
GPVRF : 0.5192 (+0.44%)
QBIO : 3.4500 (-0.29%)
SNYR : 0.3350 (+4.69%)
ACBFF : 7.5300 (-4.32%)
CVSI : 1.6300 (+17.27%)
RSASF : 0.3020 (-22.44%)
COSM : 6.1500 (+8.85%)
GRWG : 4.2700 (-0.47%)
GTBP : 2.0500 (+0.49%)
ZYXI : 3.1000 (-6.06%)
PURE : 0.7000 (+16.67%)
CXDO : 2.7500 (+3.77%)
BCTXF : 0.1300 (+1.56%)
TAOIF : 0.3082 (+3.81%)
BNOEF : 0.3950 (+3.03%)
NMKEF : 0.6820 (+7.69%)
CNNRF : 4.0300 (-0.98%)
ZEST : 1.4500 (-3.33%)
HEOFF : 0.9007 (-2.43%)
ITHUF : 5.6246 (-2.18%)
COTQF : 0.3740 (-4.30%)
OTCM : 27.8100 (-3.34%)
DCTH : 2.8000 (+1.82%)
AEYE : 0.2310 (+0.43%)
VFFIF : 5.6657 (-1.64%)
TITXF : 0.1930 (-1.03%)
NMGRF : 0.2313 (+3.63%)
GLDLF : 0.6800 (+1.49%)
SNNVF : 5.9500 (+0.90%)
IWSY : 1.3100 (-0.76%)
ARTH : 0.4640 (+1.98%)
IRNC : 0.7000 (-23.08%)
PNGZF : 0.1650 (+13.79%)
NTSFF : 0.9154 (-1.71%)
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

NEW YORK , March 8, 2018 /PRNewswire/ -- OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market...

EVLLF : 0.7640 (-6.49%)
KSHB : 5.1100 (+0.29%)
DMIFF : 0.2900 (-3.33%)
OPRX : 10.40 (+0.29%)
CORVF : 1.7697 (+1.71%)
IMPZY : 1.6000 (unch)
CBWTF : 0.9600 (-4.81%)
CHPE : 18.1250 (+0.14%)
ATMS : 1.0101 (unch)
RSSS : 1.7000 (-0.58%)
FSSN : 0.1700 (+3.03%)
MSRT : 0.2500 (-1.96%)
GPVRF : 0.5192 (+0.44%)
QBIO : 3.4500 (-0.29%)
SNYR : 0.3350 (+4.69%)
ACBFF : 7.5300 (-4.32%)
CVSI : 1.6300 (+17.27%)
COSM : 6.1500 (+8.85%)
RSASF : 0.3020 (-22.44%)
GTBP : 2.0500 (+0.49%)
ZYXI : 3.1000 (-6.06%)
GRWG : 4.2700 (-0.47%)
PURE : 0.7000 (+16.67%)
CXDO : 2.7500 (+3.77%)
BCTXF : 0.1300 (+1.56%)
TAOIF : 0.3082 (+3.81%)
BNOEF : 0.3950 (+3.03%)
NMKEF : 0.6820 (+7.69%)
CNNRF : 4.0300 (-0.98%)
ITHUF : 5.6246 (-2.18%)
HEOFF : 0.9007 (-2.43%)
ZEST : 1.4500 (-3.33%)
COTQF : 0.3740 (-4.30%)
OTCM : 27.8100 (-3.34%)
DCTH : 2.8000 (+1.82%)
AEYE : 0.2310 (+0.43%)
TITXF : 0.1930 (-1.03%)
VFFIF : 5.6657 (-1.64%)
NMGRF : 0.2313 (+3.63%)
GLDLF : 0.6800 (+1.49%)
SNNVF : 5.9500 (+0.90%)
IWSY : 1.3100 (-0.76%)
ARTH : 0.4640 (+1.98%)
IRNC : 0.7000 (-23.08%)
PNGZF : 0.1650 (+13.79%)
NTSFF : 0.9154 (-1.71%)
Arch Therapeutics to Provide Corporate Update at the 30th Annual Roth Conference on March 12, 2018

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the 30 Annual Roth...

ARTH : 0.4640 (+1.98%)
Arch Therapeutics Reports Favorable Results in Repeat Dose Testing of AC5(TM) for Subchronic Systemic Toxicity

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices reported that AC5(TM) Topical Gel (AC5(TM)) was found to be biocompatible...

ARTH : 0.4640 (+1.98%)
Arch Therapeutics to Provide Corporate Update at the 19th Annual Rodman & Renshaw Global Investment Conference In New York City September 10-12, 2017

Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the 19 Annual Rodman...

ARTH : 0.4640 (+1.98%)
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5(TM) Topical Gel

Company achieves milestone of its first U.S. regulatory filing for a medical device

ARTH : 0.4640 (+1.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade ARTH with:

Key Turning Points

2nd Resistance Point 0.4779
1st Resistance Point 0.4710
Last Price 0.4640
1st Support Level 0.4561
2nd Support Level 0.4481

See More

52-Week High 0.8900
Fibonacci 61.8% 0.6455
Fibonacci 50% 0.5700
Fibonacci 38.2% 0.4945
Last Price 0.4640
52-Week Low 0.2500

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar